| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quince Therapeutics, Inc. (QNCX) has 7 insiders with recent SEC Form 4 filings, including 5 buys and 47 sells. QNCX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 739.9K | $699.2K | - | |
| COO | 45.2K | $42.7K | - | |
| ? | 39.2K | $37.0K | - | |
| ? | 29.4K | $27.8K | - | |
| ? | 21.8K | $20.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Detke Michael J.70 | Chief Medical Officer | Sale+OE | 10,000 | $100.00 | $1,000,000.00 | -100% | -85.8% | -98.1% | |
| Jul 7, 2021 | Detke Michael J.70 | Chief Medical Officer | Sale+OE | 58,261 | $54.04 | $3,148,172.24 | -58.0% | +72.0% | -95.7% | |
| Jun 28, 2021 | Lowe Christopher P.77 | COO &Chief Financial Officer | Sale+OE | 20,000 | $54.15 | $1,083,073.50 | -51.9% | +72.2% | -95.8% | |
| Jun 28, 2021 | McLoughlin Margaret58 | Director | Sell | 550 | $55.15 | $30,332.50 | -55.0% | +72.2% | -95.8% | |
| May 10, 2021 | Lynch Casey | Chief Executive Officer | Sell | 30,000 | $34.58 | $1,037,360.76 | -0.8% | +195.6% | -88.9% | |
| Mar 24, 2021 | Lamond David66 | Director | Buy | 50,000 | $33.77 | $1,688,500.00 | +2.8% | +68.3% | -81.4% | |
| Mar 22, 2021 | Lynch Casey | Chief Executive Officer | Sell | 30,000 | $35.59 | $1,067,610.75 | -0.7% | +56.0% | -82.9% | |
| Mar 4, 2021 | Lamond David66 | Director | Buy | 50,000 | $35.34 | $1,767,057.34 | +0.7% | - | - | |
| Feb 3, 2021 | Lynch Casey | Chief Executive Officer | Sell | 60,000 | $38.49 | $2,309,599.92 | -0.3% | - | - | |
| Dec 14, 2020 | Holsinger Leslie | Executive Vice President | Sale+OE | 40,000 | $30.81 | $1,232,528.00 | -30.0% | - | - |